Holding(s) in Company

6 May 2021

Instem plc
("Instem" or the "Company")

Holding(s) in Company

As previously announced, on 19 April 2021 DWTH Holdings, Inc (“DWTH”) notified the Company of its interest  in 868,203 Ordinary Shares of ten pence each in the capital of the Company (“Ordinary Shares”). These Ordinary Shares were issued to DWTH as part of the consideration for the acquisition of d-Wise Technologies, Inc (“d-Wise”) which legally completed on 1 April 2021.

On 30 April 2021, DWTH confirmed to the Company that, as intended, registered ownership of these Ordinary Shares had been transferred to the two d-Wise founding shareholders and 16 other d-wise shareholders. Accordingly, DWTH no longer has in interest in Ordinary Shares.

A Standard form for notification of major holdings (TR1) can be found here.

For further information, please contact:

Instem plc Via Walbrook
Phil Reason, CEO  
Nigel Goldsmith, CFO  
N+1 Singer (Nominated Adviser & Broker) +44 (0) 20 7496 3000
Peter Steel / Alex Bond  
Rachel Hayes  
Wallbrook Financial PR Tel: +44 (0) 20 7933 8780
Nick Rome instem@walbrookpr.com
Tom Cooper  
Nicholas Johnson  

About Instem

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

Instem solutions are in use by over 600 customers worldwide, including all the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem products and services address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform at some stage of their development.

To learn more about Instem solutions and its mission, please visit instem.com.